These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 18355658

  • 1. Circulating lipid hydroperoxides predict cardiovascular events in patients with stable coronary artery disease: the PREVENT study.
    Walter MF, Jacob RF, Bjork RE, Jeffers B, Buch J, Mizuno Y, Mason RP, PREVENT Investigators.
    J Am Coll Cardiol; 2008 Mar 25; 51(12):1196-202. PubMed ID: 18355658
    [Abstract] [Full Text] [Related]

  • 2. Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: a longitudinal analysis of the PREVENT study.
    Walter MF, Jacob RF, Jeffers B, Ghadanfar MM, Preston GM, Buch J, Mason RP, PREVENT study.
    J Am Coll Cardiol; 2004 Nov 16; 44(10):1996-2002. PubMed ID: 15542282
    [Abstract] [Full Text] [Related]

  • 3. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
    Chiang KH, Huang PH, Huang SS, Wu TC, Chen JW, Lin SJ.
    Coron Artery Dis; 2009 Jun 16; 20(4):267-73. PubMed ID: 19440065
    [Abstract] [Full Text] [Related]

  • 4. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
    Sabatine MS, Morrow DA, O'Donoghue M, Jablonksi KA, Rice MM, Solomon S, Rosenberg Y, Domanski MJ, Hsia J, PEACE Investigators.
    Arterioscler Thromb Vasc Biol; 2007 Nov 16; 27(11):2463-9. PubMed ID: 17766330
    [Abstract] [Full Text] [Related]

  • 5. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease.
    Koga H, Sugiyama S, Kugiyama K, Watanabe K, Fukushima H, Tanaka T, Sakamoto T, Yoshimura M, Jinnouchi H, Ogawa H.
    J Am Coll Cardiol; 2005 May 17; 45(10):1622-30. PubMed ID: 15893178
    [Abstract] [Full Text] [Related]

  • 6. Paraoxonase and arylesterase activities in coronary artery disease.
    Gur M, Aslan M, Yildiz A, Demirbag R, Yilmaz R, Selek S, Erel O, Ozdogru I.
    Eur J Clin Invest; 2006 Nov 17; 36(11):779-87. PubMed ID: 17032345
    [Abstract] [Full Text] [Related]

  • 7. Level of high-sensitivity C-reactive protein in Saudi patients with chronic stable coronary artery disease.
    Habib SS.
    J Ayub Med Coll Abbottabad; 2008 Nov 17; 20(2):3-6. PubMed ID: 19385446
    [Abstract] [Full Text] [Related]

  • 8. Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events.
    Healy AM, Pickard MD, Pradhan AD, Wang Y, Chen Z, Croce K, Sakuma M, Shi C, Zago AC, Garasic J, Damokosh AI, Dowie TL, Poisson L, Lillie J, Libby P, Ridker PM, Simon DI.
    Circulation; 2006 May 16; 113(19):2278-84. PubMed ID: 16682612
    [Abstract] [Full Text] [Related]

  • 9. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.
    Nozaki T, Sugiyama S, Koga H, Sugamura K, Ohba K, Matsuzawa Y, Sumida H, Matsui K, Jinnouchi H, Ogawa H.
    J Am Coll Cardiol; 2009 Aug 11; 54(7):601-8. PubMed ID: 19660689
    [Abstract] [Full Text] [Related]

  • 10. Markers of eosinophilic inflammation and risk prediction in patients with coronary artery disease.
    Falcone C, Minoretti P, D'Angelo A, Buzzi MP, Coen E, Emanuele E, Aldeghi A, Olivieri V, Geroldi D.
    Eur J Clin Invest; 2006 Apr 11; 36(4):211-7. PubMed ID: 16620281
    [Abstract] [Full Text] [Related]

  • 11. Usefulness of combining serum uric acid and C-reactive protein for risk stratification of patients with coronary artery disease (Bezafibrate Infarction Prevention [BIP] study).
    Brodov Y, Behar S, Goldenberg I, Boyko V, Chouraqui P.
    Am J Cardiol; 2009 Jul 15; 104(2):194-8. PubMed ID: 19576345
    [Abstract] [Full Text] [Related]

  • 12. Markers of endothelial dysfunction in the prediction of coronary artery disease in type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study.
    Costacou T, Lopes-Virella MF, Zgibor JC, Virella G, Otvos J, Walsh M, Orchard TJ.
    J Diabetes Complications; 2005 Jul 15; 19(4):183-93. PubMed ID: 15993351
    [Abstract] [Full Text] [Related]

  • 13. Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Varughese GI, Patel JV, Tomson J, Blann AD, Hughes EA, Lip GY.
    J Intern Med; 2007 Apr 15; 261(4):384-91. PubMed ID: 17391113
    [Abstract] [Full Text] [Related]

  • 14. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
    Huang PH, Lu TM, Wu TC, Lin FY, Chen YH, Chen JW, Lin SJ.
    Coron Artery Dis; 2008 May 15; 19(3):187-93. PubMed ID: 18418236
    [Abstract] [Full Text] [Related]

  • 15. Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease.
    Shechter M, Issachar A, Marai I, Koren-Morag N, Freinark D, Shahar Y, Shechter A, Feinberg MS.
    Int J Cardiol; 2009 May 01; 134(1):52-8. PubMed ID: 18479768
    [Abstract] [Full Text] [Related]

  • 16. The relationship of circulating endothelial cells to plasma indices of endothelial damage/dysfunction and apoptosis in acute coronary syndromes: implications for prognosis.
    Boos CJ, Balakrishnan B, Blann AD, Lip GY.
    J Thromb Haemost; 2008 Nov 01; 6(11):1841-50. PubMed ID: 18761720
    [Abstract] [Full Text] [Related]

  • 17. The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study.
    Mohler ER, Ballantyne CM, Davidson MH, Hanefeld M, Ruilope LM, Johnson JL, Zalewski A, Darapladib Investigators.
    J Am Coll Cardiol; 2008 Apr 29; 51(17):1632-41. PubMed ID: 18436114
    [Abstract] [Full Text] [Related]

  • 18. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.
    Yeboah J, Klein K, Brosnihan B, Reboussin D, Herrington DM.
    Menopause; 2008 Apr 29; 15(6):1060-4. PubMed ID: 18521047
    [Abstract] [Full Text] [Related]

  • 19. Smoking is associated with epicardial coronary endothelial dysfunction and elevated white blood cell count in patients with chest pain and early coronary artery disease.
    Lavi S, Prasad A, Yang EH, Mathew V, Simari RD, Rihal CS, Lerman LO, Lerman A.
    Circulation; 2007 May 22; 115(20):2621-7. PubMed ID: 17485580
    [Abstract] [Full Text] [Related]

  • 20. Markers for endothelial dysfunction, but not markers for oxidative stress correlate with classical risk factors and the severity of coronary artery disease. (A subgroup analysis from the Ludwigshafen Risk and Cardiovascular Health Study).
    Ruef J, März W, Winkelmann BR.
    Scand Cardiovasc J; 2006 Oct 22; 40(5):274-9. PubMed ID: 17012137
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.